Rossi 2002.

Study characteristics
Methods	Trial design: randomised, investigator‐blinded, parallel study Trial registration number: not reported Country: UK, France, and Germany, assumed from the list of affiliations Outpatient or hospital: Secondary care, assumed from the list of affiliations Date trial conducted: not reported Duration of trial participation: 3 weeks Inclusion criteria: not reported; however, title stated AD Exclusion criteria: not reported Additional design details: none
Participants	Total number randomised: 152 enrolled; unclear how many were randomised participants Age, sex: ethnicity, duration of eczema, severity of eczema, body site, number of withdrawals: not reported Notes: none
Interventions	Run‐in details: not reported Intervention: flucortolone 0.5% ointment used at unspecified frequency for up to 3 weeks · Concurrent treatment: not reported · Other key information: none Comparator: desonide 0.05% lotion used at unspecified frequency for up to 3 weeks · Concurrent treatment: not reported · Other key information: none Concurrent treatments received alongside both intervention and comparator: not reported Notes: none
Outcomes	· Efficacy: sum of scores for erythema, infiltration/papulation, excoriation, lichenification and oozing/crusting · Pruritus · Safety
Notes	Funding source: not reported Declarations of interest: not declared Original language of publication: English Other: this study has previously been extracted by this group; some content is reproduced from Lax 2022.